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Abstract
Background: Hepatocellular carcinoma (HCC) is one of most common and aggressive human malignancies in the
world, especially, in eastern Asia, and its mortality is very high at any phase. We want to investigate mechanism of
niclosamide inducing cell apoptosis in HCC.
Methods: Two hepatoma cell lines were used to evaluate activity of niclosamide inducing cell apoptosis and study
its mechanism. Quantitative real-time PCR and western blotting were used in analysis of genes expression or protein
active regulated by niclosamide.
Results: Niclosamide remarkably induced cell apoptosis in hepatoma cells. Furthermore, our study revealed that
RNA-dependent protein kinase-like kinase (PERK) is activated and its expression is up-regulated in HCC cells which
are exposed to niclosamide. niclosamide also significantly increase activating transcription factor 3 (ATF3), activating
transcription factor 4 (ATF4) and CCAAT/enhancer-binding protein-homologous protein (CHOP) expression in HCC
cells. It’s suggested that the function of niclosamide was abrogated by PERK inhibitor or absent ATF3. Expression of PERK
and CHOP is correlated with ATF3 level in the cells.
Conclusion: Taken together, our results indicate that ATF3 plays an integral role in ER stress activated and cell
apoptosis induced by niclosamide in HCC cells. In this study, the new mechanism of niclosamide as anti-cancer
we investigated, too.
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Background
Hepatocellular carcinoma (HCC) is one of the most
common and aggressive human malignancies in the
world [1]. It is a major public health issue worldwide
according to epidemiological data, and the incidence is
high in East Asia.
HCC often develops caused by chronic tissue damage
due to liver cirrhosis which could be induced by HBV,
HCV, alcohol intake, hemochromatosis, nonalcoholic
steatohepatits and so on [2].
Surgical resection is the primary treatment option for
patients with early stage of HCC [2]. After surgical treat-
ment, patients should accept chemotherapy. However
the rate of total 5-years survival is very low due to side
effects of chemotherapeutic drugs and the chemo-
resistance of tumor cells. Therefore it is very important
to develop new drugs for HCC treatment [3]. It is well
known that Endoplasmic Reticulum (ER) stress could
induce cell apoptosis or cell death in many tumor
categories, including breast cancer [4], neuroectodermal
tumor [5], HCC [6], etc. ER stress could activate un-
folded protein response (UPR) whose signaling network
consists of three stress sensors, namely protein kinase
RNA like ER kinase (PERK) or RNA-dependent protein
kinase-like kinase, inositol-requiring enzyme 1α (IRE1α),
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and activating transcription factor 6 (ATF6) [7]. In can-
cer cells, UPR could be activated by exposure to hypoxia,
oxidative stress and nutrient starvation. The tumor
microenvironment usually features hypoxia and high
content of reactive oxygen species (ROS) because of the
highly active proliferation and metabolism status of cancer
cells. Hypoxia and ROS could direct PERK activation,
which in turn activates eukaryotic translation initiation
factor 2α (eIF2α) which would induce the expression of
activating transcription factor 4 (ATF4) for regulating
redox homeostasis and metabolic homeostasis [8]. How-
ever CCAAT/enhancer-binding protein-homologous pro-
tein (CHOP, also known as GADD153), a downstream
element to ATF4 in the PERK pathway, induces apoptosis
or cell death under intensive or prolonged ER stress con-
ditions [9, 10]. Interestingly, activating transcription factor
3 (ATF3), a bZIP DNA-binding protein, is associated with
CHOP and thus integrated into the PERK/eIF2α pathway
under ER stress backgrounds [11]. Expression of ATF3
could be induced by ER stress and involved in regulation
of cell apoptosis [12]. In the tumors, ATF3 might induce
cell apoptosis or improve cell survival depending on
tumor types. Currently, several studies have shown that
ATF3 plays tumor suppressing roles in different cancer
types, including colon cancer [11] and esophageal squa-
mous cell carcinomas (ESCC) [13]. It’s also reported that
the overexpression of ATF3 suppresses growth of HeLa
cells [14]. Other data showed that niclosamide, an antihel-
minthic drug for treatment of tapeworm infections ap-
proved by FDA, has exhibited anticancer function in
different tumor types, including leukemia, colon cancer,
glioma, etc [15]. We hypothesized that niclosamide also
has effective function in anti-HCC. In this study, We
demonstrated a new mechanism of niclosamide as anti-
cancer with HCC cells.
Methods
Cell culture and drug treatment
HepG2 and QGY7701 cell lines were obtained from the
Cell Bank of Shanghai Institute of Cell Biology (Chinese
Academy of Sciences, Shanghai) and maintained in DMED
(Hyclone, Logan, UT,) high glucose medium, supple-
mented with 10 % FBS (Gibco, NY). All cells were cul-
tured in humidified 37 °C incubator supplied with 5 %
CO2. Niclosamide (Sigma-Aldrich, St. Louis, MO) was
dissolved in DMSO (Sigma-Aldrich, St. Louis, MO). To
explore the regulation of niclosamide upon signal path-
ways, cells were seeded in 6-well plate and incubated for
24 h. Then cells were fed with fresh medium containing
different concentrations of niclosamide or DMSO only
as control. After 24 h of niclosamide treatment, cells
was lysed with 1 % SDS lysis buffer (1%SDS,25 mM
EDTA, 45 mM Tris-HCl, ph6.5) for western analysis,
and total RNA was isolated directly with Trizol reagent
(Life technologies, CA). In order to block ER stress,
GSK2606414 (Selleck Chemicals, Houston, TX) was
used to pretreat cells for 1 h before cells treated with
niclosamide.
DNA constructs and lenti-virus packaging
Oligo of ATF3 shRNA was synthesized and inserted in
pGV298 lentiviral vector (GeneChem, Shanghai). The
ATF3 target sequence was 5’-GCAAAGTGCCGAAAC
AAGA-3’ according to as described in publication [16].
The control GFP shRNA plasmid was purchased from
GeneChem inc (GeneChem, Shanghai). The lentiviral
vector is cotransfected with pVSV-G, pRev, pTat and
pGag-pol (Gifts from Dr. Cheng, UMCM, Baltimore) in
order to produce lentivirus particles in HEK293T cells
with lipfectimin2000 (life technologies, CA) and super-
natant were collected and were used to transduce
HepG2 cells.
Stable ATF3 knockout HepG2 cell line
HepG2 cells were planted to 6-well plate and incu-
bated overnight. Cells were fed with medium contained
ATF3 shRNA lentivirus particles and 10 μg.ml−1 poly-
brene(Santa Cruz, CA) which could improve the effi-
ciency of lentivirus transduction. The medium was
changed after 24 h of lentivirus transduction. Positive cells
were selected with 10 μM puromycin (Santa Cruz, CA)
and efficiency of ATF3 knockout was analyzed with
western blotting.
Cell viability assay
HepG2 and QGY7701 cells were seeded to 96-well plates
and incubated overnight. Cells were fed with fresh
complete medium containing different concentrations of
niclosamide every 24 h and maintained for 3 days. Then
cell viability was analyzed with CCK8 kit (Dojindo, Japan).
Data were normalized with control group and presented
as average ± SD. For the analysis of cell viability in ATF3
knock-down HepG2 and control cell lines, HepG2-
ATF3KD and HepG2-control cells were planted in 96-well
plates. Cells were treated with niclosamide or DMSO and
cell number was counted every day for three days. Data
was presented as average ± SD. Student t-test was used in
statist analysis.
Terminal deoxynucleotidyl transferase-mediated dUTP
nick end labeling (TUNEL) assay
TUNEL assay was performed to analyze cells apoptosis
induced by niclosamide. HepG2 and QGY7701 cells
grown on polylysine-coated cover slides were fixed with
4 % Paraformalclehyde after 24 h of 10 μM niclosamide
treatment. TUNEL APO-GREEN detect kit (biotool,
Shanghai, China) was used in DNA labeling according
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to manufacturer’s instruction. Images were taken by
NIKON fluorescence microscope (Nikon, Japan).
Flow cytometry
HepG2 and QGY7701 cells were treated with niclosa-
mide, niclosamide/GSK2606414 or DMSO as control.
Cells were harvested at 24 h of drug treatment and
washed twice with cold PBS on ice. Cell pellets were
resuspended with PBS and FITC-Annexin V Apoptosis
Detection Kit (Wanlei Bio, Shenyang, China) was used
to stain cells according to manufacturer’s manual
book. Cells apoptosis were analyzed with flow cytometer
(BD Bioscience, US).
RNA preparation and quantitative real-time PCR
Total RNA was extracted with Trizol reagents (Life
technologies, CA) according to manufacturer’s instruc-
tion. Reverse transcription and quantitative Real-time
PCR (qRT-PCR) were performed as previously described
[17]. For detecting gene expression induced by niclosa-
mide, ATF3 and ER stress associated genes were selected
for qRT-PCR and GAPDH was used as control. All
primers were synthesized by Life technologies company
(Shanghai, China) and the sequences were listed in Table 1.
2 μg total RNA was used as template to synthesize the first
strand of cDNA with M-MLV reverse transcriptase
(Takara, Dalian, China) in a 20 μl reaction system. PCR re-
actions were carried out with 200x diluted cDNAs,
100 nmol of each primer, and SYB Premix Ex Taq II
(TaKaRa, Dalian, China) in a 20 μl reaction system.
qRT-PCR reactions were performed with ABI (life tech-
nologies, CA) and PCR parameters involved the following
steps: 95 °C for 5 min, 1 cycle; 94 °C for 5 s and 60 °C for
30 s, 40 cycles. Final data were normalized with GAPDH
and presented as ratio to control.
Western immunoblotting
Western immunoblotting was performed as previously de-
scribed [15]. The primary antibodies used in this study were
anti-cleaved caspase 3 and anti- phospho-eIF2α (Ser51)
(Cell signaling tech, Danvers), anti-GAPDH (Proteintech,
Chicago), anti-ATF4 (Wanlei Bio, Shenyang, China),
anti-GADD153/CHOP (Wanlei Bio, Shenyang,China),
anti-ATF3, anti-eIF2α, anti-pPERK and anti-PERK
(Santa Cruz biotech, Santa Cruz). HRP conjunct
secondary Antibodies were purchased from Jackson
immune Research-laboratories (Western Grove, PA).
The PVDF membrane was purchased from Millipore
(Millipore, Billerica) and ECL substrate was purchased
from Thermo Fisher (Thermo Fisher, Waltham).
Immunofluorescence staining and confocal microscopy
HepG2 and QGY7701 cells were grown on polylysine-
coated cover slides and were fixed with cold methanol
after 24 h of 2 μM niclosamide treatment. The cells were
incubated in block buffer (3%BSA in TBST) at room
temperature (RT) for 30 min. Then, anti-ATF3 or anti-
GADD153/CHOP antibodies was diluted to 1:100 in
blotting buffer (1 % BSA in TBST with 0.3 % TritonX-100)
and were used to blot cells overnight at 4 °C. After the
cells were washed three times with TBST, Alex®488-goat
anti-rabbit IgG (Life technologies, CA) were used to incu-
bate cells at RT for 1 h. Cell nucleus was stained with
Hoechst 33342 (Sigma-Aldrich, St. Louis, MO). Confocal
images were taken with Leica SP8 confocal microscope
(Leica, Wetzlar, Germany).
Table 1 Primers for qRT-PCR
Gene Accession Gene ID Primer Sequence
NM_001030287 ATF3 Forward(5’-3’) CGAAGACTGGAGCAAAATG ATG
Reverse(5’-3’) CATCCAGGCCAGGTCTCTGCCTCAG
NM_001675 ATF4 Forward(5’-3’) TGGACTTCGAGCAAGAGATG
Reverse(5’-3’) AGGAAGGAAGGCTGGAAGAG
NM_001195053 DDIT3(CHOP) Forward(5’-3’) TGCTTTCAGGTGTGGTGATG TATG
Reverse(5’-3’) AATCAGAGCTGGAACCTGAGGA
NM_004836 EIF2AK3(PERK) Forward(5’-3’) CTTATGCCAGACACACAGGA CAA
Reverse(5’-3’) TCCATCTGAGTGCTGAATGGAATAC
NM_007348 ATF6A Forward(5’-3’) GCCGCCGTCCCAGATATTA
Reverse(5’-3’) GCAAAGAGAGCAGAATCCCA
NM_001433 ERN1(IRE1A) Forward(5’-3’) ATTGTGTACCGGGGCATGTT
Reverse(5’-3’) TTCTCCGTGCAGAAGTAGCG
NM_001256799 GAPDH Forward(5’-3’) CTCAGACACCATGGGGAAG GTGA
Reverse(5’-3’) ATGATCTTGAGGCTGTTGTCATA
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Statistical analysis
All calculations and statistical analyses were performed
with Excel software (Microsoft, WA). Student t test was
used in comparing two groups in experiments. All data
were presented as average ± SD. All tests were two-
sided, and P values less than 0.05 were considered to be
statistically significant.
Results
Niclosamide suppressed cells growth by inducing
ER-stress in HCC cells
Niclosamide significantly suppressed HCC growth in
vitro as indicated by results of cell viability assay (Fig. 1a,
b). The results of western blotting showed that niclosa-
mide remarkably activated caspase-3 active and level of the
poly ADP-ribose polymerase (PARP), a substrate of acti-
vated caspase-3, in niclosamide treatment cells was signifi-
cantly less than in control cells (Fig. 1c, d, e). These data
demonstrated activity of inducing apoptosis in hepatoma
cells. To investigate the role of in ER-stress, the transcrip-
tion levels of PERK, ATF6 and IRE1α, which are expressed
specifically under the background of ER-stress, were ana-
lyzed using qRT-PCR. Interestingly, mRNA level of PERK
but not ATF6 or IRE1α was significantly upregulated by
niclosamide in both of HepG2 and QGY7701 cells
(Fig. 2a).
ATF4 and CHOP are the most important downstream
genes in the PERK-eIF2α pathway and modulate cell
apoptosis [9]. Therefore, the expression of ATF3, ATF4
and CHOP were analyzed with RT-PCR and results
showed that all of their mRNA levels were remarkably
increased after niclosamide treatment (Fig. 2b, c, d). It’s
also shown in our study that CHOP mRNA level was in-
creased by over 20 times. To identify whether PERK
pathway is activated by niclosamide, different doses of
niclosamide was used to treat hepatoma cells and certain
protein levels were analyzed with western blotting. We
found protein levels of ATF4, ATF3 and CHOP, which
are important transcription factors of the PERK pathway,
were significantly increased in a dose dependent manner
in accordance with the elevation of PERK protein level
(Fig. 3a, b). In turn, phosphorylation of eIF2α was en-
hanced by active PERK (Fig. 3a, c). Interestingly, under
normal conditions ATF3 level was low in HCC cells, but
its elevation was more significant than ATF4 or CHOP
(Fig. 3b). Our data suggested that niclosamide also
activated caspase3 in both HepG2 and QGY7701 cells
(Fig. 3a).
Niclosamide increased nuclear accumulation of ATF3
and CHOP in HCC
ATF3 and CHOP are critical transcription factors in the
PERK pathway and they should bind to DNA to regulate
gene transcription. To investigate whether ATF3 and
CHOP upregulated by niclosamide localized in nucleus
of hepatoma cells, Anti-ATF3 and Anti-CHOP primary
Fig. 1 Niclosamide suppresses cell growth and induces cell apoptosis in hepatoma cells. a QGY7701 and HepG2 cells were treated with indicated
concentrations of niclosamide and cell viability was analyzed using CCK-8 assay after 72 h of niclosamide treatment. Data from three independent
experiments were normalized with DMSO control cells and presented as average ± SD. ** indicates p < 0.01. b QGY7701 and HepG2 cells were
treated with 10 μM of niclosamide or equal volume of DMSO for 24 h. Cell apoptosis was analyzed with TUNEL assay, and apoptosis cell nuclei
were labelled by FITC(Green) and all nuclei were stained with Hoechst 33342(Blue). Bar represents 50 μm. c Ratio of Nuclei of apoptosis cell was
analyzed(n = 500). data Data was presented as average ± SD. **p < 0.01. d Cells were treated with 10 μM of niclosamide or equal volume of DMSO
for 24 h. Cells were lysed with 1 % SDS lysis buffer and cleaved-caspase-3 and PARP protein level were analyzed with western blotting and GAPDH
was used as loading control. e and f Results of western blotting was analyzed with Gel Image system software (Tanon) and data were presented as
ratio of target protein to GAPDH in the form of grayscale value
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antibodies was used in immunofluorescence assays. The
results showed that niclosamide increase both ATF3 and
CHOP levels and increase their accumulation in the nu-
cleus of HepG2 and QGY7701 cells (Fig. 4a, b). These
results demonstrated that niclosamide might upregulate
ATF3 and CHOP expression, and such expression
products would localize in nucleus to exert their roles.
Niclosamide induced apoptosis in the HCC suppressed by
PERK inhibition
Since PERK pathway was activated by niclosamide, we
tried to investigate whether PERK pathway had its roles
in the apoptosis induced by niclosamide. Our data
showed that GSK2606414, an inhibitor of PERK path-
way, could improve cell survival under niclosamide
treatment (Fig. 5a). The results of western blot showed
that GSK2606414 significantly suppress activation of
caspase3 in HepG2 and QGY7701 cells (Fig. 5b). Ac-
cording to the cell flow cytometry assay data for cell
apoptosis, GSK2606414 decrease percentage of apop-
totic cells after niclosamide treatment (Fig. 5c). These
evidences confirmed that PERK pathway contributes to
cells apoptosis induced by niclosamide.
ATF3 upregulation during cell apoptosis induced by
niclosamide
To verify the role of ATF3 in ER stress activated by
niclosamide in HCC, we tried to down-regulate ATF3 in
hepatoma cell lines with small hair RNA (ATF3-shRNA)
targeting ATF3 gene and GFP gene (GFP-shRNA) as
control. Our data showed there is no difference in cell
proliferation between control cells and ATF3 knock-
down (ATF3KD) cells in normal cell culture medium.
However, ATF3KD cells had higher cell viability than
control cells post niclosamide treatment (Fig. 6a). ATF3
knock-down might abrogate PERK and CHOP expres-
sion induced by niclosamide (Fig. 6b, c, d). In turn,
ATF3 knock-down also reduced caspase3 activity
Fig. 2 Expression of PERK signal pathway related genes was induced by niclosamide in hepatoma cells. QGY7701 and HepG2 cells were harvested and
total RNA was extracted post treatment with 10 μM niclosamide in the medium for 24 h. a Expression level of PERK and its downstream genes, b ATF4,
c ATF3 and d CHOP, were analyzed with qRT-PCR. Data were normalized with control group and presented as change-fold. All experiments were
repeated for at least three times. ** indicates p < 0.01
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Fig. 3 Niclosamide induced PERK activation and the expression of PERK downstream genes in hepatoma cells. a QGY7701 and HepG2 cells were
planted in 6-well plates and cultured overnight. Cells were fed with fresh complete DMEM medium (10%FBS) with indicated concentration of
niclosamide or DMSO. Cells were harvested and lysed with 1 % SDS lysis buffer after 24 h of niclosamide treatment. 30 μg of total protein was
seperated by SDS-PAGE for immune-blotting. Commercial primary antibodies were used to probe target protein or phosphorylated protein on
membrane. Signal of western blotting was captured by Tanon Gel Image system. b Results of western blotting were analyzed with Gel Image system
software (Tanon) and data were presented as ratio of target protein to GAPDH in the form of grayscale value. c Relative phosphorylated eIF2α level
was analyzed with western blotting and data were presented as ratio of phosph-eIF2α to total eIF2α in the form of grayscale value
Fig. 4 Niclosamide improved ATF3 and CHOP accumulation in the nucleus. QGY7701 or HepG2 cells were treated with 5 μM niclosamide or
equal volume of DMSO in the medium for 24 h. Cells were immunostained using (a) anti-ATF3 antibdy or (b) anti-CHOP as described in Material
and methods. The scan bar represented 10 μm
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induced by niclosamide (Fig. 6b). So our data suggested
that ATF3 plays a central role in ER-stress activated
and apoptosis induced by niclosamide in HepG2 cells.
Discussion
In this study, our data suggested that niclosamide re-
markably induced cell apoptosis (Fig. 1b) and increase
expression level of PERK and its down-stream genes in
HCCs (Fig. 2). It’s known that sustaining ER stress could
sequentially activate IRE1α, ATF6 and PERK pathways
[4, 8]. PERK/ATF4/CHOP pathway is one of most
important pathways to induce cancer cell apoptosis in
the UPR [18]. ATF3 is an important factor for stress
response in cells and it interact with ATF4 and CHOP,
Fig. 5 PERK inhibitor could atteneuate cell apoptosis induced by niclosamide in hepatoma cells. a QGY7701 and HepG2 cells were maintained
with indicated drugs (2 μM of niclosamide or 2 μM of niclosamide + 5 μM of GSK2606414) in the medium for 72 h, DMSO was used as control.
Cell viability was analyzed with CCK-8. b QGY7701 and HepG2 cells were harvested and lysed with 1 % SDS lysis buffer after 24 h of treatment
with indicated drug. Western blotting was used to analyze levels of phospho-PERK, total PERK and cleaved caspase-3 in the cell lysate. c QGY7701
and HepG2 cells were treated with indicated drugs for 24 h. Then, cells were harvested and stained with FITC-Annexin V and PI for apoptosis
assay with flow cytometry
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these two transcription factors being PERK targeting
genes under ER stress conditions [5, 9]. Current study
demonstrated that ATF3 was involved in regulation of
PERK function [19]. We further tried to reveal whether
their protein levels are related with dose of niclosamide
or not. Data of western blotting indicated that niclosa-
mide upregulates PERK, ATF4, ATF3 and CHOP de-
pending on the niclosamide concentration (Fig. 3). The
results also demonstrated that caspase-3 is activated
under niclosamide treatment (Fig. 3). Many studies had
shown that niclosamide blocked cancer cells prolifera-
tion in a number of tumors types by suppressing the ac-
tivities of several oncogenic pathways, including NF-kB,
STAT3, notch and Wnt [20-22]. It also increases the
level of reactive oxygen species (ROS) in acute myeloge-
nous leukemia cells and enhances sensitivity to ROS in
lung cancer cells [23]. Recently, it was identified that
niclosamide could suppress HCC proliferation by block-
ing Wnt pathway [24]. Interestingly, we found that
PERK pathway should play a critical role in HCC apop-
tosis induced by niclosamide. The apoptosis-inducing
role of niclosamide in HCC could be abrogated by PERK
inhibitor, GSK2606414 (Fig. 5). Several studies have
suggested PERK/ATF4/CHOP pathway being involved in
regulation of cells apoptosis and death in HCC [6, 25, 26].
Current studies have demonstrated that ATF3 plays an
integral role in the PERK-eIF2α pathway in regulation of
downstream gene expression when ER-stress is activated
[27]. ATF3 is integrated in the PERK pathway, and its
expression is regulated by PERK [19]. In the PERK path-
way, ATF3 also modulates CHOP expression and regu-
lates eIF2α activation by negative feedback [27]. In
clinical HCC samples, the expression level of ATF3 is
significantly low [28]. It’s also reported that ATF3 ex-
pression was low in HepG2 and QGY7701 cells. Niclosa-
mide not only increases ATF3 mRNA and protein levels
in HCCs, but also stimulates ATF3 accumulation in nu-
cleus of HepG2 or QGY7701 cells (Fig. 4a). Because
ATF3 functions in regulation of cancer cell survival and
apoptosis depending on tumor types, its function in
HCC was still unclear. Our data showed that downregu-
lation of ATF3 expression level in HepG2 could remark-
ably abrogate effects of niclosamide on cell viability and
activate caspase-3 level (Fig. 6a, b, c). Especially, PERK
and CHOP expression levels were lower in ATF3 knock
down cells than wild type cells either with or without
Fig. 6 ATF3 was involved in modulation of cell apoptosis induced by niclosamide. a ATF3 knockdown HepG2 cell line (HepG2-ATF3KD) and control cell
lines (GFP knockdown, HepG2-Control) was treated with indicated chemicals for 24 h and cells were harvested and lysed with 1 % SDS lysis buffer. 30 μg
of total protein was seperated by SDS-PAGE for western blotting assay. Indicated primary antibodies were used for immunoblotting. HepG2-ATF3KD and
HepG2-control cells were planted in 96-well plates and maintained (b) without or with (c) 10 μM of niclosamide for 3 days. Cell number was countered
every day. Data from three independent experiments were analyzed and presented as average ± SD. ** indicates p< 0.01. D and E, HepG2-ATF3KD and
HepG2-Control cells were treated with or without 10 μM of niclosamide for 24 h. Then, total RNA was extracted and cDNA was synthesized.
Relative mRNA level of (d) PERK and (e) CHOP were analyzed with qRT-PCR. Data was presented as average ± SD. *p < 0.05,**p < 0.01
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niclosamide treatment (Fig. 6d, e). Several observations
suggested that ATF3, an integrated player coordinating
the expression of ER stress response related genes,
directly regulates target gene expression which induce
cell death or apoptosis in p53-dependent or independent
ways in cancer cells under ER stress [16, 19]. It represses
cancer-related chemokine expression and regulates can-
cer cells micro-environment under ER stress [11]. In our
study, expression of ER stress target genes was repressed
in an ATF3-absent condition in HepG2 and QGY7701
cells. Our study demonstrates a series of crucial roles of
ATF3 in PERK/CHOP pathway activation and cells
apoptosis induction resulting from niclosamide treat-
ment in HCC (Fig. 7).
Conclusion
Our study reveals that niclosamide activates PERK and
up-regulates both of ATF3 and CHOP expression in
HCCs. The function of niclosamide could be abrogated
by PERK inhibitor and suppression of ATF3 expression.
Especially, ATF3 upregulates PERK and CHOP level in
HCCs being exposed to niclosamide. Our data indicates
that ATF3 plays a central role in the induction of cell
apoptosis by niclosamide in HCC.
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